Literature DB >> 4281877

A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients.

A Forsman, E Mårtensson, G Nyberg, R Ohman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4281877     DOI： 10.1007/bf00501606

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  11 in total

1.  [Cardiovascular actions of Haloperidol].

Authors:  H SCHMITT; H SCHMITT
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-05-01

2.  Neurolept-analgesia--an alternative to general anaesthesia.

Authors:  E NILSSON; P JANSSEN
Journal:  Acta Anaesthesiol Scand       Date:  1961       Impact factor: 2.105

3.  Circulatory response to tilt with some anti-emetic and sedative drugs.

Authors:  A B DOBKIN; V G CRISWICK
Journal:  Can Anaesth Soc J       Date:  1961-07

4.  Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.

Authors:  T N Chase
Journal:  Arch Neurol       Date:  1973-11

5.  Long-term effects of haloperidol.

Authors:  P L Man
Journal:  Dis Nerv Syst       Date:  1973-02

6.  [Chromatographic analysis of some butyrophenones of pharmaceutical use].

Authors:  M P Quaglio; G S Cavicchi; M Muraglia
Journal:  Boll Chim Farm       Date:  1971-07

7.  A method for the gas chromatographic determination of butyrophenones.

Authors:  F Marcucci; L Airoldi; E Mussini; S Garrattini
Journal:  J Chromatogr       Date:  1971-07-08

8.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

9.  A gas chromatographic method for the determination of haloperidol in human plasma.

Authors:  I A Zingales
Journal:  J Chromatogr       Date:  1971-01-06

10.  [Intoxications by butyrophenones].

Authors:  M Gaultier; D Fahti
Journal:  Eur J Toxicol       Date:  1971 Sep-Oct
View more
  13 in total

1.  Individual variability in response to haloperidol.

Authors:  A O Forsman
Journal:  Proc R Soc Med       Date:  1976

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.

Authors:  P Arlock; B Gullberg; S R Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

Review 4.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

5.  Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.

Authors:  R Ohman; M Larsson; I M Nilsson; J Engel; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

6.  Rapid isolation with Sep-Pak C18 cartridges and wide-bore capillary gas chromatography of some butyrophenones.

Authors:  H Seno; O Suzuki; T Kumazawa; M Asano
Journal:  Z Rechtsmed       Date:  1989

7.  Pharmacokinetics of haloperidol in psychotic patients.

Authors:  Y F Cheng; L K Paalzow; U Bondesson; B Ekblom; K Eriksson; S O Eriksson; A Lindberg; L Lindström
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

9.  Substantial rise in sparteine metabolic ratio during haloperidol treatment.

Authors:  L F Gram; D Debruyne; V Caillard; J P Boulenger; J Lacotte; M Moulin; E Zarifian
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 10.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.